Costas A. Lyssiotis
- Cancer Research top 0.1%
- Cancer, Hypoxia, and Metabolism 46
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research 18
- Molecular Biology top 0.5%
- Epigenetics and DNA Methylation 29
- Mitochondrial Function and Pathology 14
- Metabolism, Diabetes, and Cancer 12
- Metabolomics and Mass Spectrometry Studies 10
- Pluripotent Stem Cells Research 10
- Biochemistry top 0.5%
- Immunology top 1%
- Immune cells in cancer 11
- Co-authors
- Lewis C. CantleyAlec C. KimmelmanChristopher J. HalbrookJohn M. AsaraMarina Pasca di MaglianoHaoqiang YingXiaoxu WangAnirban Maitra
- Partner nations
- United StatesChinaJapan
In The Last Decade
Costas A. Lyssiotis
140 papers receiving 13.2k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Cancer Research 4.8k
- Oncology 3.7k
- Molecular Biology 8.2k
- Biochemistry 689
- Immunology 1.9k
Countries citing papers authored by Costas A. Lyssiotis
This map shows the geographic impact of Costas A. Lyssiotis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Costas A. Lyssiotis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Costas A. Lyssiotis more than expected).
Fields of papers citing papers by Costas A. Lyssiotis
This network shows the impact of papers produced by Costas A. Lyssiotis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Costas A. Lyssiotis. The network helps show where Costas A. Lyssiotis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Costas A. Lyssiotis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 7 | |
| 8 | 2023 | 10 | |
| 9 | Arginase 1 is a key driver of immune suppression in pancreatic cancerbreakdown → | 2023 | 96 |
| 10 | 2022 | 27 | |
| 11 | 2021 | 10 | |
| 12 | Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balancebreakdown → | 2021 | 188 |
| 13 | 2021 | 147 | |
| 14 | 2020 | 147 | |
| 15 | 2018 | 27 | |
| 16 | 2016 | 67 | |
| 17 | 2016 | 251 | |
| 18 | 2015 | 139 | |
| 19 | Influence of Threonine Metabolism on S -Adenosylmethionine and Histone Methylationbreakdown → | 2012 | 506 |
| 20 | 2012 | 336 |
About Costas A. Lyssiotis
Costas A. Lyssiotis is a scholar working on Cancer Research, Biochemistry and Physiology, having authored 144 papers that have together received 13.3k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (46 papers), Epigenetics and DNA Methylation (29 papers), Pancreatic and Hepatic Oncology Research (18 papers), Mitochondrial Function and Pathology (14 papers), Metabolism, Diabetes, and Cancer (12 papers), Immune cells in cancer (11 papers), Metabolomics and Mass Spectrometry Studies (10 papers) and Pluripotent Stem Cells Research (10 papers). The work is most often cited by research in Cancer Research (4.8k citations), Oncology (3.7k citations) and Molecular Biology (8.2k citations). Costas A. Lyssiotis has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Lewis C. Cantley, Alec C. Kimmelman, Christopher J. Halbrook, John M. Asara, Marina Pasca di Magliano, Haoqiang Ying, Xiaoxu Wang, Anirban Maitra, Ng Shyh‐Chang and Peter G. Schultz.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.